Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > We are in the negotiation phase with a global top 10 pharma

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Jan 23, 2022 1:16pm

168 Views

Post# 34350037

RE:RE:RE:RE:RE:We are in the negotiation phase with a global top 10 pharma

Well tickley wiggles, you need to have another look because it appears that these companies are now paying attention. Just read the new releases and take the most positive interpretation of the words if you are not sure. Its hard to believe them, I know, I know.

IF one new global pharma signs on, be prepared to see other agreements follow. Just in my opinion.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”